Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006

• Published in: PloS one Vol. 5; no. 11; p. e13957
• Main Authors: Aspelund, Thor, Gudnason, Vilmundur, Magnusdottir, Bergrun Tinna, Andersen, Karl, Sigurdsson, Gunnar, Thorsson, Bolli, Steingrimsdottir, Laufey, Critchley, Julia, Bennett, Kathleen, O'Flaherty, Martin, Capewell, Simon
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 12.11.2010; Public Library of Science (PLoS)
• Subjects: Adult; Age; Aged; Analysis; Archives & records; Blood pressure; Cardiovascular agents; Cardiovascular disease; Cardiovascular diseases; Cholesterol; Clinical trials; Coronary artery disease; Coronary Disease - mortality; Coronary Disease - prevention & control; Diabetes; Diabetes mellitus; Disease prevention; Evidence-based medicine; Fatalities; Female; Food supply; Health risks; Health services; Heart; Heart attack; Heart diseases; Heart failure; Hospitals; Humans; Hypertension; Iceland - epidemiology; Incidence; Life expectancy; Male; Mens health; Meta-analysis; Middle Aged; Models, Statistical; Mortality; Mortality - trends; Myocardial infarction; Myocardial Infarction - mortality; Myocardial Infarction - prevention & control; Physical activity; Population; Population statistics; Prevention; Public health; Public Health and Epidemiology; Public Health and Epidemiology/Epidemiology; Public Health and Epidemiology/Global Health; Public Health and Epidemiology/Health Policy; Public Health and Epidemiology/Preventive Medicine; Quality of life; Risk analysis; Risk factors; Sensitivity analysis; Smoking; Statins; Studies; Surgery; Therapeutics; Tobacco; Trends; Womens health; Iceland; United Kingdom > UK; England; United States > US
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0013957

Coronary heart disease (CHD) mortality rates have been decreasing in Iceland since the 1980s. We examined how much of the decrease between 1981 and 2006 could be attributed to medical and surgical treatments and how much to changes in cardiovascular risk factors. The previously validated IMPACT CHD mortality model was applied to the Icelandic population. The data sources were official statistics, national quality registers, published trials and meta-analyses, clinical audits and a series of national population surveys. Between 1981 and 2006, CHD mortality rates in Iceland decreased by 80% in men and women aged 25 to 74 years, which resulted in 295 fewer deaths in 2006 than if the 1981 rates had persisted. Incidence of myocardial infarction (MI) decreased by 66% and resulted in some 500 fewer incident MI cases per year, which is a major determinant of possible deaths from MI. Based on the IMPACT model approximately 73% (lower and upper bound estimates: 54%-93%) of the mortality decrease was attributable to risk factor reductions: cholesterol 32%; smoking 22%; systolic blood pressure 22%, and physical inactivity 5% with adverse trends for diabetes (-5%), and obesity (-4%). Approximately 25% (lower and upper bound estimates: 8%-40%) of the mortality decrease was attributable to treatments in individuals: secondary prevention 8%; heart failure treatments 6%; acute coronary syndrome treatments 5%; revascularisation 3%; hypertension treatments 2%, and statins 0.5%. Almost three quarters of the large CHD mortality decrease in Iceland between 1981 and 2006 was attributable to reductions in major cardiovascular risk factors in the population. These findings emphasize the value of a comprehensive prevention strategy that promotes tobacco control and a healthier diet to reduce incidence of MI and highlights the potential importance of effective, evidence based medical treatments.